본문 바로가기

Pleurodesis Using Mistletoe Extract Delivered via a Spray Catheter during Semirigid Pleuroscopy for Managing Symptomatic Malignant Pleural Effusion

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q1
저널
RESPIRATION95(3) · pp.177 · 2018
피인용
Web of Science 8Scopus 9
FWCI (Scopus)
0.57
JCR IF
JCR 2017 2.591
ISSN
0025-7931

저자

  1. 엄중섭제1저자교신저자Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  2. 안효영Department of Thoracic and Cardiovascular Surgery, Pusan National University School of Medicine, Busan, South Korea
  3. 목정하Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  4. 이기원Department of Radiology, Pusan National University School of Medicine, Busan, South Korea
  5. 조은정Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  6. 김미현Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  7. 이광하Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  8. 김기욱Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  9. 박혜경Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
  10. 이민기Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea

초록

Background: Talc poudrage during thoracoscopy is considered the standard procedure for patients with symptomatic malignant pleural effusion (MPE). Until now, no alternative technique other than talc poudrage for pleurodesis during medical thoracoscopy has been proposed. Liquid sclerosants, such as mistletoe extract, have been sprayed evenly into the pleural cavity during semirigid pleuroscopy for chemical pleurodesis. Objective: We conducted a retrospective study using the database of semirigid pleuroscopy to identify the usefulness of pleurodesis using a mistletoe extract delivered via a spray catheter during semirigid pleuroscopy for symptomatic MPE. Methods: All consecutive patients with symptomatic MPE who underwent semirigid pleuroscopy from October 2015 to September 2016 were registered. The responses were evaluated using chest X-ray or computed tomography 4 weeks after pleurodesis. Results: The study included 43 patients who underwent pleurodesis with mistletoe extract via a spray catheter during semirigid pleuroscopy. Complete and partial responses were seen in 21 (49%) and 19 (44%) patients, respectively. The median duration of chest tube placement after pleurodesis was 7 days (range 6-8 days) in the 40 patients with complete or partial responses. No cases of severe hemorrhage, empyema formation, respiratory failure, or procedure-related mortality were observed in the subjects at 4 weeks after semirigid pleuroscopy. Conclusion: Pleurodesis with mistletoe extract delivered via a spray catheter during semirigid pleuroscopy is a safe and effective procedure for managing symptomatic MPE. (C) 2017 S. Karger AG, Basel

키워드

Malignant pleural effusionMistletoePleurodesisPleuroscopyTALC POUDRAGEMANAGEMENTTHORACOSCOPYSLURRY

식별자

Scopus EID
2-s2.0-85033478062
WoS UID
000427733000006